Clinical trial
Randomized Phase II Study of Vinflunine as Maintenance Monotherapy in Patients With Advanced or Metastatic Urothelial Cancer That Obtains Clinical Benefit of the First Line With Cisplatin-gemcitabine Combination
NCT01529411 is registered in ClinicalTrials.gov with Spanish Oncology Genito-Urinary Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II Study of Vinflunine as Maintenance Monotherapy in Patients With Advanced or Metastatic Urothelial Cancer That Obtains Clinical Benefit of the First Line With Cisplatin-gemcitabine Combination
- Lead sponsor
- Spanish Oncology Genito-Urinary Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- December 31, 2014
- Enrollment
- 86 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.